Cholangiocarcinoma Market - Top Companies and Manufacturers

Companies Dominating the Cholangiocarcinoma Market

Verismo Therapeutics, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Eli Lilly and Company
AstraZeneca plc
Merck Sharp & Dohme LLC.
Basilea Pharmaceutica Ltd.
Incyte Corporation
Agios Pharmaceuticals Inc.
Specialised Therapeutics Asia Pte Ltd (ST)
PlantPraxis Biotecnologia
Dr. Reddy’s Laboratories Ltd.

Browse Key Market Insights with Data Illustration:

Cholangiocarcinoma Market Size & Share | Forecast Report 2036

In the News

Verismo Therapeutics, a clinical-stage CAR T company and pioneer of the novel KIR-CAR platform technology, announced that it had received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SynKIR-110, an investigational new drug administered intravenously for the treatment of mesothelin-expressing mesothelioma, cholangiocarcinoma, and ovarian cancer.
AstraZeneca, a global pharmaceutical company, announced that Imfinzi (durvalumab), a human monoclonal antibody that binds to the PD-L1 protein, had been approved in the U.S. by the FDA for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin).

Frequently Asked Questions (FAQ)

The increasing Research & development and rising awareness about cholangiocarcinoma are the major factors driving the growth of the cholangiocarcinoma market.

The market size of cholangiocarcinoma is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2024-2036.

The major players in the market are Eli Lilly and Company, AstraZeneca, Merck Sharp & Dohme Corp, Basilea Pharmaceutica, Incyte Corporation, Agios Pharmaceuticals, Specialised Therapeutics, PlantPraxis Biotecnologia, Dr. Reddyâ€™s Laboratories, and others.

The retail pharmacy segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Cholangiocarcinoma Market - Top Companies and Manufacturers

Companies Dominating the Cholangiocarcinoma Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the cholangiocarcinoma market?

What would be the CAGR of the cholangiocarcinoma market over the forecast period?

Who are the major players dominating the cholangiocarcinoma market?

Which segment captures the largest market size in the distribution channel segment in the cholangiocarcinoma market?

Which region will provide more business opportunities for the growth of the cholangiocarcinoma market in the future?